Loading your workspace…
All markets
Who will testify to congress about Epstein?
Foretrace AI research
Understand the odds. Examine the reasoning.
Polymarket shows market prices. Foretrace adds AI probability estimates, opposing evidence and a price-dependent outcome or pass decision for each open market.
View a sample AI report No open markets in this event. Closed markets retain historical data.
24h volumeUnavailable
Total volume$63.4K
LiquidityUnavailable
Event end date · UTCJun 30, 2026
Price history
Market probabilityLoading price history…
Polymarket · UTC
Sampled market observations, not AI forecasts. Lines connect available observations. Legend values are current provider quotes; chart points may be older.
Outcomes & resolution rules
8 marketsThese are market-implied probabilities, not AI forecasts. A displayed quote may differ from the price available for your order.
Ex-Prince AndrewClosedMarket odds0%
Will Ex-Prince Andrew Testify to Congress about Epstein?
Yes0%Polymarket estimate
No100%Polymarket estimate
- Liquidity
- Unavailable
- Deadline · UTC
- Jun 30, 2026
- Yes bid / ask
- — / 0.1¢
- Trading fees
- Enabled · verify on Polymarket
Closed market · historical data
This market is closed. Its historical data remains available.
How research worksResolution rules
This market will resolve to "Yes" if the listed individual provides testimony about Jeffrey Epstein before either chamber of the United States Congress (House of Representatives or Senate), or any of their official committees or subcommittees, by June 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". Qualifying testimony may be either live or recorded, in-person or remote, and closed or open to the public. A primary focus of the testimony must be information related to Jeffrey Epstein, including but not limited to the listed individuals’ relationship with Epstein, their appearance in Epstein-related files released by the federal government, their involvement in previous Epstein investigations or criminal proceedings, or their general knowledge of Epstein and his life. Limited references to Epstein in an otherwise unrelated congressional testimony will not qualify. The resolution source for this market will be a consensus of credible reporting.